Safety and tolerability of bosentan for digital ulcers in Japanese patients with systemic sclerosis: Prospective, multicenter, open-label study-Reference-Cited by-同舟云学术

Safety and tolerability of bosentan for digital ulcers in Japanese patients with systemic sclerosis: Prospective, multicenter, open-label study

Published:2016-07-04 Issue:1 Volume:44 Page:13-17
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Hamaguchi Yasuhito¹,Sumida Takayuki²,Kawaguchi Yasushi³,Ihn Hironobu⁴,Tanaka Sumiaki⁵,Asano Yoshihide⁶,Motegi Sei-ichiro⁷,Kuwana Masataka⁸,Endo Hirahito⁹,Takehara Kazuhiko¹

Affiliation:

1. Department of Dermatology; Faculty of Medicine; Institute of Medical; Pharmaceutical and Health Sciences; Kanazawa University; Kanazawa Japan

2. Department of Internal Medicine; Faculty of Medicine; University of Tsukuba; Tsukuba Japan

3. Institute of Rheumatology; Tokyo Women's Medical University; Tokyo Japan

4. Department of Dermatology and Plastic Surgery; Faculty of Life Sciences, Kumamoto University; Kumamoto Japan

5. Department of Collagen Disease and Infection Medicine; Kitasato University Hospital; Sagamihara Japan

6. Department of Dermatology; University of Tokyo Graduate School of Medicine; Tokyo Japan

7. Department of Dermatology; Gunma University Graduate School of Medicine; Maebashi Japan

8. Division of Rheumatology; Department of Internal Medicine; Keio University School of Medicine; Tokyo Japan

9. Department of Internal Medicine; Toho University School of Medicine; Tokyo Japan

Funder

Actelion Pharmaceuticals

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.13497/fullpdf

Reference21 articles.

1. Epidemiology and natural history of systemic sclerosis;Steen;Rheum Dis Clin North Am,1990

2. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology;Tan;Adv Immunol,1989

3. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis;LeRoy;J Rheumatol,1988

4. Digital ulcers: overt vascular disease in systemic sclerosis;Steen;Rheumatology (Oxford),2009

5. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis;Kuwana;Arthritis Rheum,1994

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of adjunctive ambrisentan treatment for digital ulcers in patients with systemic sclerosis: a case series study;Journal of Dermatological Treatment;2023-12-10

2. Aprocitentan, a dual endothelin-1 (ET-1) antagonist for treating resistant hypertension: Mechanism of action and therapeutic potential;Drug Discovery Today;2023-11

3. Domain reporting in Systemic Sclerosis-Related Digital Ulcers: An OMERACT Scoping Review;Seminars in Arthritis and Rheumatism;2023-08

4. Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review;Rheumatology;2023-06-19

5. Retrospective Analysis of Patients with Systemic Sclerosis Using Bosentan for Digital Ulcer: A Ten-Year Single Center Experience;Uludağ Üniversitesi Tıp Fakültesi Dergisi;2023-06-09